NCT03493906View on ClinicalTrials.gov

Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During Treatment

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Acute Leukemia
Interventions
OTHER

Patient Ambassador Support

Patient Ambassador Support, with former patient treated for acute leukaemia being ambassadors for newly diagnosed patients for a period of 12 weeks.

Trial Locations (3)

2100

Rigshospitalet, Copenhagen

2730

Herlev Hospital, Herlev

4000

Sjællandsuniversitetshospital Roskilde, Roskilde

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT03493906 - Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During Treatment | Biotech Hunter | Biotech Hunter